ArticleFrontiers in cardiovascular medicine2026
Case Report: Hereditary ATTR-CA presenting with recurrent severe abdominal cramps: a diagnostic challenge.
Article in Frontiers in cardiovascular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Hereditary transthyretin cardiac amyloidosis (ATTR-CA) is a rare autosomal dominant systemic disorder characterized by amyloid deposition in the peripheral nerves, myocardium, kidneys, and gastrointestinal tract. The clinical manifestations of ATTR-CA are nonspecific, resulting in high rates of misdiagnosis and underdiagnosis. Case presentation: We report the case of a 58-year-old woman who presented with recurrent severe abdominal pain and echocardiographic evidence of ventricular hypertrophy. Initial cardiac magnetic resonance imaging at an outside institution suggested left ventricular non-compaction (LVNC). Prior to receiving the correct diagnosis, she was incorrectly diagnosed with chronic cholecystitis, somatic symptom disorder, or LVNC at multiple institutions. A multidisciplinary team evaluation integrating cardiac imaging, technetium-99m phosphate scintigraphy, and genetic testing confirmed the diagnosis of ATTR-CA associated with the Ser23Asn (TTR c.128G>A p.Ser43Asn) variant. She was treated with tafamidis but died suddenly only two months after diagnosis. This case illustrates the multisystem involvement of ATTR-CA, in which atypical presentations frequently result in diagnostic delays. It represents a rarely reported instance of ATTR-CA presenting primarily with severe recurrent abdominal pain. Conclusion: In patients with ventricular hypertrophy, ATTR-CA may manifest with atypical symptoms such as severe, recurrent abdominal pain, which can result from autonomic neuropathy or gastrointestinal amyloid deposition. When the clinical diagnosis remains uncertain, multidisciplinary team consultation is essential to synthesize all available findings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.